Details for New Drug Application (NDA): 206615
✉ Email this page to a colleague
The generic ingredient in BUTALBITAL, ACETAMINOPHEN AND CAFFEINE is acetaminophen; butalbital; caffeine. There are sixty-six drug master file entries for this compound. Thirty-seven suppliers are listed for this compound. Additional details are available on the acetaminophen; butalbital; caffeine profile page.
Summary for 206615
Tradename: | BUTALBITAL, ACETAMINOPHEN AND CAFFEINE |
Applicant: | Key Therap |
Ingredient: | acetaminophen; butalbital; caffeine |
Patents: | 0 |
Pharmacology for NDA: 206615
Physiological Effect | Central Nervous System Stimulation |
Suppliers and Packaging for NDA: 206615
Tradename | Generic Name | Dosage | NDA | Application Type | Supplier | National Drug Code | Package Code | Package |
---|---|---|---|---|---|---|---|---|
BUTALBITAL, ACETAMINOPHEN AND CAFFEINE | acetaminophen; butalbital; caffeine | CAPSULE;ORAL | 206615 | ANDA | Proficient Rx LP | 71205-962 | 71205-962-00 | 100 CAPSULE in 1 BOTTLE (71205-962-00) |
BUTALBITAL, ACETAMINOPHEN AND CAFFEINE | acetaminophen; butalbital; caffeine | CAPSULE;ORAL | 206615 | ANDA | Proficient Rx LP | 71205-962 | 71205-962-30 | 30 CAPSULE in 1 BOTTLE (71205-962-30) |
Profile for product number 001
Active Rx/OTC/Discontinued: | DISCN | Dosage: | CAPSULE;ORAL | Strength | 300MG;50MG;40MG | ||||
Approval Date: | Aug 4, 2017 | TE: | RLD: | No |
Complete Access Available with Subscription